Intracerebroventricular pitolisant impairs long-term potentiation in rats, suggesting caution in neurological use.
Objectives: The histaminergic system plays a vital role in memory function, but the underlying cellular and circuit mechanisms remain poorly understood. Pitolisant, an inverse agonist of the histamine H3 receptor (H3R), is widely used in the treatment of narcolepsy and has shown potential anti-seizure effects. However, its impact on memory and synaptic plasticity is unclear. This study investigated the effects of intracerebroventricular administration of pitolisant on passive avoidance memory consolidation. Meanwhile, the impact of pitolisant on synaptic excitability, short-term plasticity, and long-term potentiation (LTP) in the hippocampus was investigated. Materials and Methods: region to assess its targeted effects. Subsequently, field potentials were recorded to measure fundamental synaptic properties: input-output (I/O) function, paired-pulse facilitation, and LTP function. Results: Pitolisant significantly impaired memory consolidation. It also reduced the fEPSP slope in I/O function and paired-pulse facilitation, suggesting impaired synaptic excitability and increased presynaptic inhibition. Additionally, LTP was reduced in pitolisant-treated groups, indicating disrupted long-term plasticity. Conclusion: These findings highlight a potential inhibitory effect of pitolisant on passive-avoidance memory consolidation in healthy rats and on hippocampal synaptic function, raising concerns about its use in neurological disorders.
No takes yet. Share an insight, caveat, or question.
Beheshti et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: